Published

Dose effect of psilocybin on primary and secondary depression: a preliminary systematic review and meta-analysis.

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Journal of affective disorders
Date: 2022-01-01
Source: PubMed
DOI: 10.1016/j.jad.2021.09.041
PubMed: 34587546

Authors

Li NX Hu YR Chen WN Zhang B

Watch author

Derived topics and classifications

psilocybin Depression Clinical Trial Meta-Analysis Systematic Review Review Article Cancer Patients Meta-Analysis

Citation graph

0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

Indexed papers citing this DOI

Methodological moderators of psilocybin-assisted therapy in depression: A systematic review and meta-analysis2026-04-01

Related papers

G33 Psychedelic drugs for the treatment of chronic pain: is ketamine included?Ask the expert - Psychedelic substances · 2024-08-31 LSD Treatment in Persons Suffering From Anxiety Symptoms in Severe Somatic Diseases or in Psychiatric Anxiety Disorders: a Randomized, Double-blind, Placebo-controlled Phase II StudyClinicalTrials.gov · 2021-12-22 Psilocybin may help cancer patients with depression and anxiety for yearsAccess Science · 2020-01-01 The Utility of Psilocybin in Managing Anxiety and Depression in Cancer PatientsBiochemistry and Molecular Biology Education · 2018-08-01